-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C/6f/95KS7V52CqDxx4BTS9JM+Y20vtzfDEcl55Qxws+MOA7WnXndAvZyHOLS1fJ v58hAMyRC+CCW8iSrZOcDA== 0000941655-03-000014.txt : 20030515 0000941655-03-000014.hdr.sgml : 20030515 20030514173627 ACCESSION NUMBER: 0000941655-03-000014 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030331 FILED AS OF DATE: 20030515 EFFECTIVENESS DATE: 20030515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC CENTRAL INDEX KEY: 0001020455 IRS NUMBER: 133087622 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05883 FILM NUMBER: 03700389 BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127516677 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: RHO MANAGEMENT CO INC DATE OF NAME CHANGE: 19960806 13F-HR 1 r03-0331.txt SCHEDULE 13F HOLDINGS REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2003 Check here if Amendment [ ]; Amendment No.: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Rho Capital Partners, Inc. Address: 152 West 57th Street 23rd Floor New York, New York 10019 13F File Number: 28-5883 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter E. Kalkanis Title: Chief Financial Officer Phone: 212-751-6677 /s/ Peter E. Kalkanis New York, New York Dated: May 14, 2003 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. I AM SIGNING THIS REPORT AS REQUIRED BY THE SECURITIES EXCHANGE ACT OF 1934. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 24 Form 13F Information Table Value Total: $68,174 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE Value Shares/ Sh/ Put/ Invstmt Other Voting Authority Name of Issuer Title of Class CUSIP (x$1000) PrnAmt Prn Call Discret Mngrs Sole Shared None ACTIVE POWER INC COM 00504W100 925 833,669 SH Sole 833,669 AGERE SYS INC CL B 00845V209 160 106,516 SH Sole 106,516 AIRSPAN NETWORKS INC COM 00950H102 1,284 1,510,253 SH Sole 1,510,253 AVANT IMMUNOTHER COM 053491106 999 899,954 SH Sole 899,954 BIOTRANSPLANT INC COM 09066Y107 122 813,273 SH Sole 813,273 CAPSTONE TURBINE CORP COM 14067D102 1,454 2,019,453 SH Sole 2,019,453 CISCO SYS INC COM 17275R102 131 10,107 SH Sole 10,107 COMMERCE ONE INC DEL COM 200693109 167 99,727 SH Sole 99,727 CYBERONICS INC COM 23251P102 22,614 1,057,239 SH Sole 1,057,239 DIACRIN INC COM 25243N103 1,780 1,694,867 SH Sole 1,694,867 DIVERSA CORP COM 255064107 15,342 1,639,153 SH Sole 1,639,153 DYAX CORP COM 26746E103 495 284,616 SH Sole 284,616 GENAERA CORP COM 36867G100 160 261,890 SH Sole 261,890 GENZYME-BIOSURGERY COM 372917708 30 25,801 SH Sole 25,801 GENZYME-MOLECULAR COM 372917500 168 115,265 SH Sole 115,265 IVILLAGE INC COM 46588H105 1,037 1,672,319 SH Sole 1,672,319 LUCENT TECHNLOGIES COM 549463107 592 402,614 SH Sole 402,614 MILLENNIUM PHARMACTLS COM 599902103 136 17,258 SH Sole 17,258 MISSION RESOURCES CORP COM 605109107 374 1,334,409 SH Sole 1,334,409 ONESOURCE INFO SVCS COM 68272J106 2,286 368,065 SH Sole 368,065 QUOVADX INC COM 74913K106 121 62,686 SH Sole 62,686 SILICON LABORATORIES COM 826919102 2,617 100,076 SH Sole 100,076 VERIDIAN CORP DEL COM 92342R203 10,620 533,691 SH Sole 533,691 VERSICOR INC COM 925314106 4,560 421,055 SH Sole 421,055
-----END PRIVACY-ENHANCED MESSAGE-----